ZenaTech, Inc. (NASDAQ: ZENA) (FSE: 49Q) (BMV: ZENA), a technology solutions provider specializing in AI-powered drones, Drone as a Service (DaaS), enterprise software and quantum computing, announced that its ZenaDrone subsidiary has signed a memorandum of understanding (MOU) with Rattler Medical Inc. to develop and manufacture a drone-based battlefield blood delivery system.
The proposed system will combine ZenaDrone’s cargo drone capabilities with Rattler Medical’s temperature-controlled blood transport containers to deliver blood to military medical personnel more quickly while reducing reliance on ground transportation in combat environments. Under the agreement, the companies plan to develop and test a flying prototype within two to three months, evaluating delivery methods that include aerial release and landing-based deployment. ZenaDrone is targeting a demonstration at a U.S. military facility in summer 2027.
The initiative expands ZenaTech’s defense portfolio into battlefield medical logistics, with the companies seeking to improve blood resupply capabilities and reduce risks associated with transporting medical supplies through contested areas. This development matters because timely access to blood can be critical for saving lives on the battlefield, and drone delivery could bypass ground routes that are often vulnerable to attack or obstruction.
ZenaTech, through its subsidiaries, focuses on AI autonomy drone platforms for commercial, government, and defense sectors. Its operations include drone manufacturing via ZenaDrone, a global DaaS business, and an enterprise SaaS division. The company is executing an acquisition-led DaaS roll-up strategy to digitize and automate legacy service industries like land surveys and inspections, driving drone-based scalable, recurring revenue growth. With an operating footprint spanning North America, Europe, the Middle East, Asia, and Australia, ZenaTech is advancing AI drones for applications such as agriculture and logistics, as well as intelligence, surveillance, and reconnaissance (ISR), cargo, and counter-UAS for U.S. defense and NATO allies. The company is also investing in next-generation technologies, including drone swarms, quantum computing, and advanced AI autonomy.
The announcement was reported by DefenseWireNews, a specialized communications platform focused on defense contractors, aerospace firms, cybersecurity leaders, advanced manufacturing innovators, and other mission-critical companies. DefenseWireNews is one of 75+ brands within the Dynamic Brand Portfolio at IBN, which provides wire solutions via InvestorWire, editorial syndication to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions.
For investors and industry observers, the MOU signals ZenaTech’s continued push into defense-related drone applications, potentially opening new revenue streams in military medical logistics. The successful development of a drone-based blood delivery system could also set a precedent for using unmanned aerial vehicles for other time-sensitive medical supply deliveries in conflict zones, with implications for both military and humanitarian operations. However, the project is still in its early stages, and the planned prototype and demonstration will be key milestones to watch.
To view the full press release, visit https://ibn.fm/xSVke. For more information about ZenaTech, visit https://www.zenatech.com/.
